Search

for
Search:

Glossary

Similar Terms

Saccharomyces cerevisiae

Learn

0 / 0 results

— no results

Research

5 / 1000+ results

Efficacy of Intramuscular Injections of Biotin and Dexpanthenol in the Treatment of Diffuse Hair Loss: A Randomized, Double-Blind Controlled Study Comparing Two Brands

research Efficacy of Intramuscular Injections of Biotin and Dexpanthenol in the Treatment of Diffuse Hair Loss: A Randomized, Double-Blind Controlled Study Comparing Two Brands

1 citations , July 2022 in “Dermatologic Therapy”

Both brands of biotin and dexpanthenol injections improved hair loss, with Bayer also increasing the ratio of thick to thin hairs.

research Sometimes Marketing Efforts by Advocacy Organizations Can Lose Touch With the Nuances of Appropriateness

November 2004 in “Oncology Times”

Advocacy groups should avoid marketing partnerships that may imply drug endorsements.

research ADT-G as a Promising Biomarker for Peripheral Hyperandrogenism in Adult Female Acne

6 citations , January 2017 in “Dermato-endocrinology”

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

research When Two Plus Two Must Not Equal Four

June 2011 in “British Journal of Urology”

Regulatory challenges make developing combination therapies in urology difficult and costly.

research Female Type of Adult Acne: Physiological and Psychological Considerations and Management

42 citations , September 2018 in “Journal der Deutschen Dermatologischen Gesellschaft”

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

View more "bayer" in research →

Community Join

5 / 62 results

community Bayer says drug research focus no longer on women´s health ( They dismissed HMI-115 because of their focus on women´s health

in Technology 4 upvotes 2 years ago

Hair loss treatments discussed include Minoxidil, Finasteride, and RU58841. Bayer dismissed HMI-115 due to focus shift away from women's health.

community HMI-115: What We Know So Far. HMI-115 (also known as BAY1158061) is a new pharmaceutical drug developed by a biopharmaceutical company called Bioinvent and licensed by Bayer

in Research/Science 51 upvotes 1 year ago

HMI-115 is a new drug developed by Bioinvent and licensed by Bayer, with mixed opinions on its potential effectiveness. Some users are skeptical and prefer proven treatments like Minoxidil, finasteride, and RU58841.

community does lowering your prolactin levels regrow hair?

in Research/Science 10 upvotes 2 years ago

The potential of lowering prolactin levels to regrow hair, with a reference to Bayer's drug HMI 115 which has been indicated as having this effect. Treatments mentioned include Minoxidil and Finasteride, as well as RU58841.

community Residents of Victoria, Australia, sign up for a monoclonal antibody clinical trial – potential cure

in Research/Science 3 years ago

A monoclonal antibody clinical trial for potential hair loss treatments in Victoria, Australia and the discussion of their efficacy. People shared information about similar drugs already on the market, speculated about potential side effects, and discussed how to spread the word about the trial.

community HLT Megathread on HMI-115 (key takeaways in comments)

in Research/Science 39 upvotes 2 years ago

HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

View more "bayer" in community →